3D Systems (DDD) Proxy filing summary

Executive summary

• Annual Meeting scheduled for May 14, 2026, to be held virtually, with stockholders encouraged to vote on key proposals and participate remotely.

• Company faced macroeconomic and geopolitical headwinds in 2025, leading to a decline in hardware revenues but resilient consumables demand.

• Significant restructuring and cost-saving initiatives were executed, including facility reductions and organizational right-sizing, while maintaining R&D investment.

• Company reorganized into Healthcare and Industrial Solutions units, targeting core markets such as dental, medical devices, aerospace, and transportation.

• Debt reduction and repositioning of maturities improved financial flexibility.

Voting matters and shareholder proposals

• Election of nine directors for one-year terms expiring at the 2027 Annual Meeting.

• Advisory vote on executive compensation for 2025 (say-on-pay).

• Ratification of Deloitte & Touche LLP as independent auditor for 2026.

• Approval to amend the Certificate of Incorporation to increase authorized common shares from 220 million to 440 million.

• Approval to amend and restate the 2015 Incentive Plan, adding 4 million shares and extending the term to 2036.

Board of directors and corporate governance

• Board consists of nine nominees, eight of whom are independent; Chair and CEO roles are separated.

• Board diversity includes a mix of gender, race/ethnicity, tenure, and industry experience.

• Annual self-evaluations and director stock ownership requirements are in place.

• Committees include Audit, Compensation, Compliance/Corporate Governance/Sustainability, and Technology Applications, all chaired by independent directors.

• Related party transactions require advance approval and are subject to a formal policy.